Screener
TriSalus Life Sciences, Inc. TLSI Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034100
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Revenue | $8,899 | $9,167 |
| Cost of goods sold | 1,230 | 1,495 |
| Gross profit | 7,669 | 7,672 |
| Operating expenses: | ||
| Research and development (1) | 3,216 | 3,021 |
| Sales and marketing | 7,413 | 6,734 |
| General and administrative (1) | 5,451 | 5,246 |
| Loss from operations | (8,411) | (7,329) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is TriSalus Life Sciences, Inc.'s total revenue?
- TriSalus Life Sciences, Inc. (TLSI) reported total revenue of $8.9M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s total revenue changed year-over-year?
- TriSalus Life Sciences, Inc.'s total revenue decreased by 2.9% year-over-year, from $9.17M to $8.9M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s total revenue?
- Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s total revenue has grown at a 56.2% compound annual growth rate (CAGR), from $18.51M to $45.15M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about TriSalus Life Sciences, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude